Item 2.02. Results of Operations and Financial Condition.
See Item 7.01-Updated Financial Guidance below, which is incorporated by reference herein.
Item 7.01. Regulation FD Disclosure.
Updated Financial Guidance
On
These preliminary revenue results are based on information available to the
Company as of
J.P. Morgan Healthcare Conference Presentation
As previously announced,
Incremental Debt Capital Raise
The Company is considering incremental debt financing in the first quarter of
2023 to further enhance liquidity due to needs associated with litigation,
including to secure collateral needed for our appeal of the adverse judgment in
the
The information in Item 2.02 and Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to liability under that section, and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, unless expressly incorporated by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit Number Description 99.1 Press Release issued bySotera Health Company , datedJanuary 9, 2023
--------------------------------------------------------------------------------
© Edgar Online, source